Jefferies Group LLC Harmony Biosciences Holdings, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$27.56 - $40.37 $280,863 - $411,410
-10,191 Closed
0 $0
Q4 2020

Sep 21, 2023
BUY
$31.74 - $51.34 $323,462 - $523,205
10,191 New
10,191 $368,000
Q4 2020

Feb 16, 2021
BUY
$31.74 - $51.34 $323,462 - $523,205
10,191 New
10,191 $368,000

Others Institutions Holding HRMY

# of Institutions
255
Shares Held
46.6M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email